Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines

@article{Gentilin2016GrowthHD,
  title={Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines},
  author={Erica Gentilin and M. E. Dellaquila Minoia and Marta Bondanelli and Federico Tagliati and Ettore Ciro degli Uberti and Maria Chiara Zatelli},
  journal={Endocrine},
  year={2016},
  volume={56},
  pages={621-632}
}
Growth Hormone may influence neoplastic development of endometrial epithelium towards endometrial adenocarcinoma, which is one of the most occurring tumors in acromegalic patients. Since chemoresistance often develops in advanced endometrial adenocarcinoma, we investigated whether Growth Hormone might influence the development of chemoresistance to drugs routinely employed in endometrial adenocarcinoma treatment, such as Doxorubicin, Cisplatin, and Paclitaxel. Growth Hormone and Growth Hormone… CONTINUE READING
BETA

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 51 REFERENCES

Cis - platin increases B - cell - lymphoma - 2 expression via activation of protein kinase C and Akt 2 in endometrial cancer cells

J. Huang, W. Hu, +16 authors A. K. Sood
  • Int . J . Cancer
  • 2012

Similar Papers

Loading similar papers…